Microbial products induce claudin-2 to compromise gut epithelial barrier function.

Area of Science:

• Gastroenterology
• Immunology
• Cell Biology

Background:

• Epithelial barrier dysfunction is a key factor in various diseases.
• The precise mechanisms underlying this dysfunction require further investigation.

Purpose of the Study:

• To investigate the role of the tight junction protein claudin-2 (Cldn2) in compromising epithelial barrier function.
• To explore Cldn2's involvement in antigen transport and its implications in food allergy.

Main Methods:

• Immunohistochemistry to assess Cldn2 expression in mouse and human intestinal tissues.
• Cell culture models (HT-29, T84 cells) to induce Cldn2 expression.
• Confocal microscopy to visualize Cldn2-facilitated antigen internalization.
• Measurement of transepithelial electrical resistance and macromolecular tracer permeability to evaluate barrier function.

Main Results:

• Cldn2 expression was significantly elevated in the small intestine of sensitized mice and food allergy patients compared to controls.
• Cholera toxin and Staphylococcal enterotoxin B induced Cldn2 expression in epithelial cell lines.
• Cldn2 was shown to bind protein antigens, facilitating their transport across the epithelial barrier.
• Blocking Cldn2 effectively prevented allergen-related intestinal hypersensitivity.

Conclusions:

• The tight junction protein Cldn2 plays a crucial role in epithelial barrier dysfunction.
• Cldn2 facilitates antigen transport across the intestinal epithelium, contributing to food allergy pathogenesis.
• Targeting Cldn2 presents a potential therapeutic strategy for managing intestinal hypersensitivity and food allergies.